Sanofi India Approves Q1 FY27 Results, Appoints New Chairman

Sanofi India Ltd's Board of Directors, at its meeting on April 28, 2026, approved the Unaudited Financial Results for the quarter ended March 31, 2026. Additionally, the tenure of Independent Directors Mr. Aditya Narayan and Mrs. Usha Thorat concluded on April 29, 2026. Mr. Rahul Bhatnagar, an Independent Director, has been appointed as the new Chairman of the Board, effective April 30, 2026. The Board also approved the reconstitution of several key committees, including the Audit, Nomination and Remuneration, Stakeholders Relationship, Risk Management, and Corporate Social Responsibility Committees, effective from April 30, 2026.